Literature DB >> 21345563

Economic evaluation to inform health care decision-making: promise, pitfalls and a proposal for an alternative path.

Astrid Brousselle1, Chantale Lessard.   

Abstract

Health economic evaluation aims at providing information on the efficiency of interventions. Since the 1980s, there have been major developments in the field, especially in terms of methodologies. As the field has expanded and developed, methodologies have become increasingly sophisticated. In parallel, over the past decade, the conduct of economic evaluations has become more and more institutionalized with, among other things, the creation of the National Institute for Health and Clinical Excellence (NICE) in England and Wales and a growing number of health technology assessment (HTA) agencies around the world. Yet the literature has identified important barriers to the use of economic evaluation in decision-making, among them the difficulty of deciphering economic evaluation research. The way the field expanded has thus created a paradox: whereas economic evaluation is seen as an insightful tool for achieving efficiency in health care, its methodological developments have decreased decision-makers' capacity to use it. In this paper, based on a literature survey, we explore this shift by first analyzing how the field of economic evaluation has developed in recent years. Second, we discuss how economic evaluation information is perceived and used in decision-making. Third, we consider a possible direction for reconciling economic evaluation and decision-making. The originality of this article is that it not only highlights the increasing gap between the aim of economic evaluation and its effective use in decision-making but also proposes, based on existing methodologies, a competing approach to the currently dominant paradigm.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Mesh:

Year:  2011        PMID: 21345563     DOI: 10.1016/j.socscimed.2011.01.008

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  19 in total

1.  How to include informal care in economic evaluations.

Authors:  Renske J Hoefman; Job van Exel; Werner Brouwer
Journal:  Pharmacoeconomics       Date:  2013-12       Impact factor: 4.981

2.  Lonely at the top and stuck in the middle? The ongoing challenge of using cost-effectiveness information in priority setting : Comment on "Use of cost-effectiveness data in priority setting decisions: experiences from the national guidelines for heart diseases in Sweden".

Authors:  Iestyn Williams; Stirling Bryan
Journal:  Int J Health Policy Manag       Date:  2015-02-15

3.  HTA for pharmaceuticals in Europe: will the mountain deliver a mouse?

Authors:  Livio Garattini; Anna Padula
Journal:  Eur J Health Econ       Date:  2020-02

4.  The Monetary Value of Informal Care: Obtaining Pure Time Valuations Using a Discrete Choice Experiment.

Authors:  Renske J Hoefman; Job van Exel; Werner B F Brouwer
Journal:  Pharmacoeconomics       Date:  2019-04       Impact factor: 4.981

Review 5.  The Value of Medicines: A Crucial but Vague Concept.

Authors:  Fernando Antoñanzas; Robert Terkola; Maarten Postma
Journal:  Pharmacoeconomics       Date:  2016-12       Impact factor: 4.981

6.  Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab Combination Therapy vs Ipilimumab Monotherapy in Patients With Advanced Unresectable Melanoma.

Authors:  Abdulaali R Almutairi; Nimer S Alkhatib; Mok Oh; Clara Curiel-Lewandrowski; Hani M Babiker; Lee D Cranmer; Ali McBride; Ivo Abraham
Journal:  JAMA Dermatol       Date:  2019-01-01       Impact factor: 10.282

7.  Cost-Utility Analysis of Chuna Manual Therapy and Usual Care for Chronic Neck Pain: A Multicenter Pragmatic Randomized Controlled Trial.

Authors:  In-Hyuk Ha; Eun-San Kim; Sook-Hyun Lee; Yoon Jae Lee; Hyun Jin Song; Younhee Kim; Koh-Woon Kim; Jae-Heung Cho; Jun-Hwan Lee; Byung-Cheul Shin; Jinho Lee; Joon-Shik Shin
Journal:  Front Med (Lausanne)       Date:  2022-05-11

8.  Evidence for the outcomes and impact of clinical pharmacy: context of UK hospital pharmacy practice.

Authors:  Raliat Onatade; Sandra Appiah; Martin Stephens; Hemda Garelick
Journal:  Eur J Hosp Pharm       Date:  2017-10-30

9.  Methods of international health technology assessment agencies for economic evaluations--a comparative analysis.

Authors:  Tim Mathes; Esther Jacobs; Jana-Carina Morfeld; Dawid Pieper
Journal:  BMC Health Serv Res       Date:  2013-09-30       Impact factor: 2.655

10.  The challenge of obtaining information necessary for multi-criteria decision analysis implementation: the case of physiotherapy services in Canada.

Authors:  Francois Dionne; Craig Mitton; Tanya Macdonald; Carol Miller; Michael Brennan
Journal:  Cost Eff Resour Alloc       Date:  2013-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.